Blog

21 February 2026

Innovative Approach to Chronic Urticaria: Targeting MRGPRX2 Explained

Discover an innovative treatment for chronic urticaria targeting MRGPRX2. Explore phase 1 data on SEP-631 and its potential to improve...
Read more
Innovative Approach to Chronic Urticaria: Targeting MRGPRX2 Explained
Revolutionizing Skin Health: The Rise of Regenerative Medicine in Dermatology

Revolutionizing Skin Health: The Rise of Regenerative Medicine in Dermatology

Discover how regenerative medicine is transforming dermatology, enhancing skin health, and reshaping medical and aesthetic practices. Learn more now!
20 02 2026
Read more
Revolutionizing Atopic Dermatitis Treatment with Gene Expression Insights

Revolutionizing Atopic Dermatitis Treatment with Gene Expression Insights

Discover how gene expression insights are revolutionizing atopic dermatitis treatment, offering personalized solutions for effective management of this complex condition.
20 02 2026
Read more
Revolutionary Blood Tests for Early Skin Cancer Detection in 2026

Revolutionary Blood Tests for Early Skin Cancer Detection in 2026

Discover revolutionary blood tests for early skin cancer detection in 2026. Learn how the Galleri test works and its accuracy...
20 02 2026
Read more
Unlocking Precision in CSU Management: The Role of Biomarkers

Unlocking Precision in CSU Management: The Role of Biomarkers

Discover how biomarkers enhance CSU management. Learn which factors predict treatment response for chronic spontaneous urticaria and improve patient outcomes.
19 02 2026
Read more
South Beach Symposium 2026: Innovations in Medical and Aesthetic Skin Care

South Beach Symposium 2026: Innovations in Medical and Aesthetic Skin Care

Discover the latest innovations in medical and aesthetic skin care at the 2026 South Beach Symposium. Join experts as they...
17 02 2026
Read more
Rezpegaldesleukin Demonstrates Long-Term Efficacy in Atopic Dermatitis Trial

Rezpegaldesleukin Demonstrates Long-Term Efficacy in Atopic Dermatitis Trial

Discover the long-term efficacy of rezpegaldesleukin in treating moderate-to-severe atopic dermatitis, as revealed in the groundbreaking REZOLVE-AD trial results.
16 02 2026
Read more
New Phase 3 Study Confirms Apremilast’s Efficacy for Genital Psoriasis

New Phase 3 Study Confirms Apremilast’s Efficacy for Genital Psoriasis

Discover how a new Phase 3 study confirms apremilast's efficacy for genital psoriasis, offering hope for those suffering from this...
15 02 2026
Read more
FDA Reviews Biofrontera’s Photodynamic Therapy for Superficial BCC

FDA Reviews Biofrontera’s Photodynamic Therapy for Superficial BCC

FDA reviews Biofrontera's Ameluz for treating superficial basal cell carcinoma (sBCC). Discover the potential expansion of this innovative photodynamic therapy.
14 02 2026
Read more